HIV-infection/Aids Clinical Trial
Official title:
Effect and Safety of Probiotic Supplementation in Immune Non-responders With HIV-1 Infection
Gut bacterial community diversity and composition, immune recovery and activation in peripheral plasma/mucosa, plasma levels of gut damage, microbial translocation and inflammation at baseline and after 6 months of receiving intervention will be analyzed.
Up to 25% of HIV-infected individuals receiving antiretroviral treatment demonstrate suboptimal blood cluster of differentiation 4（CD4） recovery despite effective viral suppression; this "immunologic non-responder" (INR) phenotype is associated with increased immune activation and with higher rates of AIDS and non-AIDS related conditions, and death. Poor gut integrity, increased microbial translocation, and reduced CD4 T-cell trafficking to the gut could be a source of ongoing inflammation in INR individuals. Researches have shown that the gut microbiota compositions are different in INRs and immunological responders (IRs). Probiotics, by modulation of gut microbiota, can help induce epithelial healing and prevent bacterial translocation. Probiotic supplementation, therefore, may be a nutritional target for INRs by boosting CD4 cell counts. We design a prospective, case-control, self-contrast study to explore the efficacy and safety of probiotic supplementation in INRs. Participants will receive oral probiotic containing 3 billion Bifidobacterium and 1 billion Lactobacillus once daily. Gut bacterial community diversity and composition, immune recovery and activation in peripheral plasma/mucosa, plasma levels of gut damage, microbial translocation and inflammation at baseline and after 6 months of receiving intervention will be analyzed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00787696 -
Healthy Teen Girls: HIV Risk Reduction
|
Phase 1/Phase 2 | |
| Completed |
NCT03403569 -
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
|
Phase 3 | |
| Completed |
NCT02433743 -
Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA
|
N/A | |
| Recruiting |
NCT02753049 -
Adherence Connection for Counseling, Education, and Support
|
N/A | |
| Completed |
NCT01360762 -
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
|
Phase 3 | |
| Recruiting |
NCT03147859 -
Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection
|
Phase 2 | |
| Completed |
NCT01827540 -
Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
|
Phase 1 | |
| Completed |
NCT01475890 -
Vitamin D Supplementation in HIV
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05947539 -
Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention
|
N/A | |
| Withdrawn |
NCT01442428 -
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
|
Phase 2/Phase 3 | |
| Completed |
NCT02496793 -
Community-Based Peer Facilitator Intervention (Zimbabwe)
|
N/A | |
| Completed |
NCT03069235 -
Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program
|
N/A | |
| Completed |
NCT03794648 -
The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication
|
N/A | |
| Withdrawn |
NCT04183738 -
Inflammation and Co-Infections in D²EFT
|
Phase 4 | |
| Enrolling by invitation |
NCT03919695 -
Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda
|
N/A | |
| Recruiting |
NCT04215926 -
NAFLD in HIV-infected Patients
|
||
| Completed |
NCT01406626 -
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
|
N/A | |
| Completed |
NCT04371835 -
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
|
||
| Completed |
NCT01140633 -
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
|
N/A | |
| Enrolling by invitation |
NCT04373551 -
WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)
|
N/A |